Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

BACKGROUND: With large waves of infection driven by the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alongside evidence of waning immunity after the booster dose of coronavirus disease 2019 (Covid-19) vaccine, several countries have begun giving at-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Magen, Ori, Waxman, Jacob G., Makov-Assif, Maya, Vered, Roni, Dicker, Dror, Hernán, Miguel A., Lipsitch, Marc, Reis, Ben Y., Balicer, Ran D., Dagan, Noa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020581/
https://www.ncbi.nlm.nih.gov/pubmed/35417631
http://dx.doi.org/10.1056/NEJMoa2201688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020581/
https://www.ncbi.nlm.nih.gov/pubmed/35417631
http://dx.doi.org/10.1056/NEJMoa2201688

Ejemplares similares